Clinical Trial Update: A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating botulinum toxin type A as a preventive treatment for chronic migraine in adolescents has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Disorders

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED | Results posted: 2017-09-05